NEUROBLASTOMA
Clinical trials for NEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new NEUROBLASTOMA trials appear
Sign up with your email to follow new studies for NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough neuroblastoma: targeted radiation trial opens
Disease control Recruiting nowThis early-stage trial tests a targeted radiation therapy (PRRT) in 18 children whose neuroblastoma has returned or not responded to standard treatments. The therapy uses a radioactive drug that seeks out tumor cells. The main goal is to find the safest dose and watch for side ef…
Matched conditions: NEUROBLASTOMA
Phase: PHASE1 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Apr 29, 2026 00:37 UTC
-
New hope for kids with high-risk neuroblastoma: drug aims to stop relapse
Disease control Recruiting nowThis study tests a drug called DFMO in children and young adults with high-risk neuroblastoma who are currently in remission. The goal is to see if taking DFMO by mouth for two years can prevent the cancer from returning. About 441 participants will take the drug and be monitored…
Matched conditions: NEUROBLASTOMA
Phase: PHASE2 • Sponsor: Giselle Sholler • Aim: Disease control
Last updated Apr 29, 2026 00:36 UTC
-
New vaccine combo aims to stop deadly childhood cancer relapse
Disease control Recruiting nowThis study is for children with high-risk neuroblastoma whose cancer is in complete remission. It tests a bivalent vaccine (with an immune booster) plus an oral beta-glucan supplement to see which schedule of beta-glucan works best to keep the cancer from returning. About 94 part…
Matched conditions: NEUROBLASTOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 00:35 UTC
-
Glow-in-the-dark dye helps surgeons spot hidden cancer in children
Diagnosis Recruiting nowThis study tests a special fluorescent dye (anti-GD2-800CW) that makes neuroblastoma tumors glow during surgery. About 22 children aged 1 to 18 will receive the dye before their standard tumor removal surgery. The goal is to find a safe and effective dose so surgeons can better s…
Matched conditions: NEUROBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Diagnosis
Last updated Apr 29, 2026 00:35 UTC
-
Scientists decode Neuroblastoma's genetic secrets to personalize treatment
Knowledge-focused Recruiting nowThis study aims to understand the genetic and biochemical makeup of neuroblastic tumors, which can affect how aggressive the cancer is and what treatments work best. Researchers will analyze tumor samples, blood, bone marrow, and stem cells from over 2000 participants. The goal i…
Matched conditions: NEUROBLASTOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Apr 29, 2026 00:37 UTC
-
Blood test could sniff out hidden neuroblastoma before it strikes
Knowledge-focused Recruiting nowThis study is looking at whether a simple blood test can find tiny bits of tumor DNA (called ctDNA) in children with neuroblastoma. The goal is to see if this test can help doctors know how well treatment is working and spot the cancer coming back earlier than usual scans. About …
Matched conditions: NEUROBLASTOMA
Sponsor: Sun Yat-sen University • Aim: Knowledge-focused
Last updated Apr 29, 2026 00:36 UTC